Matching slides 58,039
Current window 28,921-28,950
Pages 1,935
Rows per page 30
Slide function: Analyze Dataclear collectionreset all

Slide function

28,921-28,950 of 58,039

filter-aware
12
Standard clinical trial swimmer plot showing treatment duration, response (PR/SD), progression (PD), death, and ongoing status.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
13
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
Data sourced from Valle J et al. N Engl J Med 2010;362:1273-1281.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
13
Clinical trial data presented at ASCO GI22.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
14
Clinical trial data presented at ASCO GI 2022.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
15
Clinical trial data presentation showing bar chart for ORR and Kaplan-Meier curve for DoR.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
22
The slide includes a 'Number at risk' table below the chart, which is standard for clinical trial survival analysis.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
27
The plot displays individual patient responses categorized by cancer type (Gastric, CRC, Cholangio, Pancreatic, Other).Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
28
Includes footnotes explaining context for hypertension and cytopenia events compared to standard chemotherapy agents.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
31
Includes a red highlight box around the '2 prior systemic therapies' row.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
33
The chart displays patient-level data including treatment duration, partial response (PR), stable disease (SD), progressive disease (PD), death, and ongoing status.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
08
The slide uses a 2x3 grid of metric cards to present financial highlights.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
09
The slide uses four donut charts to visualize revenue composition across different business dimensions.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
10
Includes a decorative image of a person in a mushroom costume; B/(W) stands for Better/(Worse).Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
13
The slide uses a consistent color scheme (green for primary focus, grey for secondary) across three donut charts.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
14
CC likely stands for Constant Currency.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
19
Includes specific footnotes detailing adjustments and acquisition-related impacts.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations Beat · SolutionLoop · Logic Chain1 hit
22
The slide outlines a deleveraging strategy, including a pause on share repurchases.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
25
Includes footnotes explaining acquisition-related costs and bad debt impact in Russia.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
27
Includes footnotes explaining the adjustments and the impact of intra-entity IP transfers.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
28
The slide provides a detailed breakdown of the numerator (net income adjustments) and denominator (weighted average shares) to arrive at Non-GAAP EPS.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
29
Includes detailed footnotes explaining the nature of the adjustments related to the HEYDUDE acquisition and IP amortization.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
30
The slide provides specific footnotes explaining the nature of the adjustments (distribution centers, inventory fair value, and Russia operations).Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
31
The table reconciles GAAP to Non-GAAP SG&A expenses for the three months ended March 31, 2022 and 2021.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
32
The slide presents two separate financial tables for two different brands.Crocs | Results Presentation Deck | 33 slides · Crocs
Conference presentation Investor relations 1 hit
05
Figures exclude Revenue and Churn associated with Lumen as a customer.Cyxtera | Results Presentation Deck | 22 slides · Cyxtera
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
06
The slide includes a footnote defining 'Stabilized Markets'.Cyxtera | Results Presentation Deck | 22 slides · Cyxtera
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
09
Cyxtera | Results Presentation Deck | 22 slidesCyxtera | Results Presentation Deck | 22 slides · Cyxtera
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
10
Figures exclude Revenue and Churn associated with Lumen as a customer.Cyxtera | Results Presentation Deck | 22 slides · Cyxtera
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
11
Includes footnotes explaining adjustments to EBITDA and EBITDAR.Cyxtera | Results Presentation Deck | 22 slides · Cyxtera
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit